المؤلفون: Kim ST; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Misoi M; Department of General Internal Medicine, Baylor College of Medicine, Houston, TX, 77030, USA., Suarez-Almazor ME; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tayar JH; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lu H; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Buni M; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Kramer J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Biology, Georgetown University, Washington, DC, 20057, USA., Rodriguez E; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hussain Z; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Gibbons DL; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Cascone T; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lu C; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Blumenschein GR; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Altan M; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Loghin ME; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tu J; Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Abdel-Wahab N; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Rheumatology and Rehabilitation, Assiut University Hospitals, Faculty of Medicine, Assiut University, El Fateh, Egypt., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Zou J; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. lwang22@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, 77030, USA. lwang22@mdanderson.org., Nurieva R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. rnurieva@mdandesron.org.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, 77030, USA. rnurieva@mdandesron.org.

المصدر: Nature communications [Nat Commun] 2024 Jul 04; Vol. 15 (1), pp. 5621. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Wilcox JA; Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chukwueke UN; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Aizer AA; Department of Radiation Oncology, Brigham and Women's Hospital / Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bale TA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brastianos PK; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Chang S; Division of Neuro-Oncology, Department of Neurosurgery, University of San Francisco California, San Francisco, CA, USA., Daras M; Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA., Forsyth P; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Garzia L; Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada., Glantz M; Department of Neurosurgery, Penn State College of Medicine, Hershey, PA, USA., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kumthekar P; The Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA., Le Rhun E; Departments of Neurology and Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Nagpal S; Division of Neuro-Oncology, Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA., O'Brien B; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pentsova E; Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Remsik J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Laboratory for Immunology of Metastatic Ecosystems, Center for Cancer Biology, VIB, Leuven, Belgium.; Department of Oncology, KU Leuven, Leuven, Belgium., Rudà R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.; Department of Neurology, Castelfranco Veneto and Treviso Hospitals, Castelfranco Veneto, Italy., Smalley I; Department of Tumor Biology, The Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Taylor MD; Division of Neurosurgery, Department of Surgery, Texas Children's Hospital, Houston, TX, USA Neuro-oncology Research Program, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Wefel J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang JT; Department of Radiation Oncology, Department of Radiation Oncology, New York University School of Medicine, New York, NY, USA., Young RJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Boire AA; Department of Neurology, Brain Tumor Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

مؤلفون مشاركون: International Leptomeningeal Metastasis Collaborative

المصدر: Neuro-oncology [Neuro Oncol] 2024 Jun 21. Date of Electronic Publication: 2024 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

المؤلفون: Nelson BE; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. benelson1@mdanderson.org., Roszik J; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed J; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barretto CMN; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nardo M; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Campbell E; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Johnson AM; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oliva ICG; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weathers SP; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cabanillas M; Department of Endocrinology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Javle M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute, Nashville, TN, USA. Vivek.Subbiah@scri.com.

المصدر: Molecular cancer [Mol Cancer] 2024 Mar 26; Vol. 23 (1), pp. 64. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Observational Study; Letter

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/pathology, Humans ; Proto-Oncogene Proteins B-raf/genetics ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Prospective Studies ; Mutation

المؤلفون: Kim MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. Electronic address: michekim@med.umich.edu., Mehta MP; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Smart DK; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Steeg PS; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Hong JA; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA., Espey MG; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA., Prasanna PG; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA., Crandon L; Touch4Life, Clarksville, MD, USA., Hodgdon C; GRASP, Baltimore, MD, USA., Kozak N; Santa Maria, CA, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Morikawa A; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Willmarth N; American Brain Tumor Association, Chicago, IL, USA., Tanner K; National Brain Tumor Society, Newton, MA, USA., Boire A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gephart MH; Department of Neurosurgery, Stanford University, Stanford, CA, USA., Margolin KA; St John's Cancer Institute, Santa Monica, CA, USA., Hattangadi-Gluth J; Department of Radiation Oncology, University of California San Diego Health, La Jolla, CA, USA., Tawbi H; Department of Melanoma Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Trifiletti DM; Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA., Chung C; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Basu-Roy U; LUNGevity Foundation, Chicago, IL, USA., Burns R; Melanoma Research Foundation, Washington, DC, USA., Oliva ICG; Department of Melanoma Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aizer AA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, USA., Anders CK; Department of Medicine, Duke University Medical Center, Durham, NC, USA., Davis J; The Radiosurgery Society, San Jose, CA, USA., Ahluwalia MS; Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Chiang V; Department of Neurosurgery and Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA., Li J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kotecha R; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA., Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Gondi V; Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL, USA., Sperduto PW; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA., Barnholtz-Sloan JS; Informatics and Data Science Program, Center for Biomedical Informatics and Information Technology, Trans-Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Rodon J; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Khasraw M; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA., Yeboa DN; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Brastianos PK; Division of Hematology/Oncology and Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Galanis E; Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA., Coleman CN; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA., Ahmed MM; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, USA. Electronic address: ahmedmm@mail.nih.gov.

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Aug; Vol. 24 (8), pp. e344-e354.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biomedical Research* , Brain Neoplasms*/therapy, United States ; Humans ; Quality of Life ; National Cancer Institute (U.S.) ; Consensus

المؤلفون: Mathew A; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Shatila M; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lai Z; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tan D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alhalabi O; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang HC; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas A; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Y; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywang59@mdanderson.org.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (8), pp. 4591-4599. Date of Electronic Publication: 2022 Sep 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Appendicitis*/surgery , Appendicitis*/chemically induced , Appendicitis*/drug therapy , Antineoplastic Agents, Immunological*/therapeutic use , Neoplasms*/drug therapy, Adult ; Humans ; Middle Aged ; Immune Checkpoint Inhibitors/adverse effects ; Retrospective Studies

المؤلفون: Kuang AG; Department of Medicine, Baylor College of Medicine (Andrew G. Kuang, Kavea Panneerselvam)., Mohajir W; Department of Internal Medicine, The University of Texas Health Science Center at Houston (Wasay Mohajir)., Panneerselvam K; Department of Medicine, Baylor College of Medicine (Andrew G. Kuang, Kavea Panneerselvam)., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (Jennifer L. McQuade, Isabella C. Glitz Oliva)., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (Jennifer L. McQuade, Isabella C. Glitz Oliva)., Khan MA; Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center (Muhammad Ali Khan, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang), Houston, TX, USA., Zhang HC; Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center (Muhammad Ali Khan, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang), Houston, TX, USA., Thomas AS; Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center (Muhammad Ali Khan, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang), Houston, TX, USA., Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center (Muhammad Ali Khan, Hao Chi Zhang, Anusha S. Thomas, Yinghong Wang), Houston, TX, USA.

المصدر: Annals of gastroenterology [Ann Gastroenterol] 2023 Jan-Feb; Vol. 36 (1), pp. 45-53. Date of Electronic Publication: 2022 Nov 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Society Country of Publication: Greece NLM ID: 101121847 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1108-7471 (Print) Linking ISSN: 11087471 NLM ISO Abbreviation: Ann Gastroenterol Subsets: PubMed not MEDLINE

المؤلفون: Ho J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mattei J; Oncology Department, Hospital Moinhos de Vento, Porto Alegre, Brazil., Tetzlaff M; Division of Dermatopathology, University of California San Francisco (UCSF), San Francisco, CA, United States., Williams MD; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., McQuade J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hanna E; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ross M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Weiser R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Su SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Frumovitz M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Meyer LA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jazaeri A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Pettaway CA; Department of Urologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Guadagnolo BA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bishop AJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mitra D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Farooqi A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bassett R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Faria S; Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nagarajan P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Frontiers in oncology [Front Oncol] 2022 Oct 17; Vol. 12, pp. 1001150. Date of Electronic Publication: 2022 Oct 17 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Vasavada S; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas (Shaleen Vasavada, Kavea Panneerselvam)., Panneerselvam K; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas (Shaleen Vasavada, Kavea Panneerselvam)., Amin R; Department of Internal Medicine, The University of Texas Health Science Center, Houston, Texas (Rajan Amin)., Varatharajalu K; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Krishnavathana Varatharajalu, Anusha S. Thomas, Yinghong Wang)., Okhuysen PC; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas (Pablo C. Okhuysen)., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (Isabella C. Glitza Oliva)., Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (Jianbo Wang)., Grivas P; Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington (Petros Grivas), USA., Thomas AS; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Krishnavathana Varatharajalu, Anusha S. Thomas, Yinghong Wang)., Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas (Krishnavathana Varatharajalu, Anusha S. Thomas, Yinghong Wang).

المصدر: Annals of gastroenterology [Ann Gastroenterol] 2022 Jul-Aug; Vol. 35 (4), pp. 393-399. Date of Electronic Publication: 2022 Jun 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Society Country of Publication: Greece NLM ID: 101121847 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1108-7471 (Print) Linking ISSN: 11087471 NLM ISO Abbreviation: Ann Gastroenterol Subsets: PubMed not MEDLINE

المؤلفون: Kim ST; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Misoi M; Department of General Internal Medicine, Baylor College of Medicine, Houston, TX, 77030, USA., Suarez-Almazor ME; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tayar JH; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lu H; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Buni M; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Kramer J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Biology, Georgetown University, Washington, DC, 20057, USA., Rodriguez E; Department of Infectious Disease, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hussain Z; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Gibbons DL; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Cascone T; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lu C; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Blumenschein GR; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Altan M; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Valero V; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Loghin ME; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Tu J; Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Abdel-Wahab N; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Rheumatology and Rehabilitation, Assiut University Hospitals, Faculty of Medicine, Assiut University, El Fateh, Egypt., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Zou J; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. lwang22@mdanderson.org.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, 77030, USA. lwang22@mdanderson.org., Nurieva R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. rnurieva@mdandesron.org.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, 77030, USA. rnurieva@mdandesron.org.

المصدر: Nature communications [Nat Commun] 2022 Apr 12; Vol. 13 (1), pp. 1970. Date of Electronic Publication: 2022 Apr 12.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis*/chemically induced , Arthritis*/drug therapy , Neoplasms*/drug therapy , Neoplasms*/etiology, CD8-Positive T-Lymphocytes ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Immunotherapy/adverse effects

المؤلفون: Piña Y; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA., Yadugiri S; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Yeboa DN; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Ferguson SD; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Forsyth PA; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA., Oliva ICG; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. ICGlitza@mdanderson.org.

المصدر: Current oncology reports [Curr Oncol Rep] 2022 Jan; Vol. 24 (1), pp. 43-54. Date of Electronic Publication: 2022 Jan 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/diagnosis , Melanoma*/therapy , Meningeal Neoplasms*/diagnosis , Meningeal Neoplasms*/therapy, Combined Modality Therapy ; Humans ; Magnetic Resonance Imaging ; Prognosis